Targeting TGF-β for treatment of osteogenesis imperfecta is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0.678. It has been cited 91 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.678
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Brittle Bone Disorders Consortium
Grant: U54AR068069
The Clinical Translational Core of BCM IDDRC
Grant: P50HD103555
USDA/ARS under Cooperative Agreement
Grant: 58-6250-6-001
NCI NIH HHS
Grant: P30 CA125123
National Institutes of Health
Grant: 3U54AR068069-08S1
DIVERSITY SUPPLEMENT: BRITTLE BONE DISORDERS CONSORTIUM OF THE RARE DISEASE CLINICAL RESEARCH NETWORK
National Institutes of Health
Grant: 1P50HD103555-01
Baylor College of Medicine Intellectual and Developmental Disabilities Research Center
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
FWCI
11.77
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals